Windlas Biotech - Quaterly Results

05 May 2023 Evaluate
The Revenue for the quarter ended  March 2023 of Rs. 1407.13 millions grew by 15.21 % from Rs. 1221.31 millions.The Net Profit of the company registered a slight decline of -24.85% to Rs. 114.48  millions from Rs. 152.33 millions.Operating Profit saw a handsome growth to 187.77 millions from 172.90 millions in the quarter ended March 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202303 202203 % Var 202303 202203 % Var 202303 202203 % Var
Sales 1407.13 1221.31 15.21 5130.83 4659.30 10.12 5130.83 4659.30 10.12
Other Income 23.34 30.05 -22.33 99.65 67.06 48.60 99.65 67.06 48.60
PBIDT 187.77 172.90 8.60 702.07 596.01 17.80 702.07 596.01 17.80
Interest 1.64 2.88 -43.06 7.86 14.17 -44.53 7.86 14.17 -44.53
PBDT 186.13 170.02 9.48 694.21 581.84 19.31 694.21 581.84 19.31
Depreciation 35.68 29.02 22.95 123.64 121.47 1.79 123.64 121.47 1.79
PBT 150.45 141.00 6.70 570.57 460.37 23.94 570.57 460.37 23.94
TAX 35.97 -11.33 -417.48 144.13 74.76 92.79 144.13 74.76 92.79
Deferred Tax -6.12 -28.50 -78.53 0.63 -26.57 -102.37 0.63 -26.57 -102.37
PAT 114.48 152.33 -24.85 426.44 385.61 10.59 426.44 385.61 10.59
Equity 104.63 108.97 -3.98 104.63 108.97 -3.98 104.63 108.97 -3.98
PBIDTM(%) 13.34 14.16 -5.74 13.68 12.79 6.97 13.68 12.79 6.97

Windlas Biotech Share Price

766.45 3.70 (0.49%)
25-Feb-2026 10:35 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1760.85
Dr. Reddys Lab 1292.80
Cipla 1335.95
Zydus Lifesciences 908.00
Lupin 2261.75
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×